Clinical Trials Logo

Clinical Trial Summary

This prospective study investigated the validity and test-retest reliability of stereopsis test using head-mount display (HMD). Contour-based circles (crossed disparity: 1,960 to 195 arc of seconds(arc secs)) were generated as separate images on a high resolution phone display (Galaxy S7; Samsung, Suwon, Korea) using a HMD (Galaxy Gear VR; Samsung, Suwon, Korea). Two images were independently projected to each eye as graded circles with random dot background. While the position of the stimulus changed from among 3 possible locations, the subjects were instructed to select the circle with disparity by pressing the corresponding position on a keypad. The results of the new HMD stereotest were compared to those from standard Randot and TNO stereotests.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03234504
Study type Observational
Source Yonsei University
Contact Jinu Han, MD
Phone +82-10-3764-7746
Email jinuhan@yuhs.ac
Status Recruiting
Phase
Start date July 24, 2017
Completion date July 2018

See also
  Status Clinical Trial Phase
Completed NCT05019950 - Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers Phase 1
Completed NCT01366339 - Tolerance and Pharmacokinetics Study of MNTX Tablets Phase 1
Completed NCT01862835 - Impact of Estradiol Addback Phase 1
Completed NCT01629446 - Lofexidine Mass Balance in Volunteers Phase 1
Completed NCT02026973 - Impact of Endogenous E2 on SSI and GH Rebound Phase 1
Completed NCT03860571 - Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers Phase 1
Completed NCT04188730 - A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution Phase 1
Completed NCT02271282 - Estradiol-Receptor Blockade in Older Men and Women Phase 1
Withdrawn NCT03291158 - Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV Phase 1
Completed NCT02802631 - Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults Phase 1